Le produit a bien été ajouté au panier.

discount label
H-KVVRFDKL-OH
Vue en 3D

Biosynth logo

H-KVVRFDKL-OH

Ref. 3D-PP43742

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-KVVRFDKL-OH
Synonymes :
  • NH2-Lys-Val-Val-Arg-Phe-Asp-Lys-Leu-OH
Description :

Peptide H-KVVRFDKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KVVRFDKL-OH include the following: IL-10 signalling blockade at the time of immunization inhibits Human papillomavirus 16 E7 transformed TC-1 tumour cells growth in mice S Chen, X Wang, X Wu, MQ Wei, B Zhang, X Liu - Cellular , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874914001026 T cells compete for access to antigen-bearing antigen-presenting cells RM Kedl , WA Rees, DA Hildeman , B Schaefer - The Journal of , 2000 - rupress.orghttps://rupress.org/jem/article-abstract/192/8/1105/38929 The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS R Gavioli , S Cellini, A Castaldello, R Voltan - Vaccine, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X07013400 Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and PJ Chefalo, CV Harding - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/3/1274/35053 An examination of the alternate MHC-I pathway: The source and nature of MHC-I complexes, peptide exchange and loading in acidified compartments PJ Chefalo - 2003 - search.proquest.comhttps://search.proquest.com/openview/3745c4f7b934bc20d304102f3726f6b3/1?pq-origsite=gscholar&cbl=18750&diss=y Exploring the structural elements of MHC-peptide-TCR interaction with analogs of VSV-8, an antigenic peptide derived from vesicular stomatitis virus NG Saito - 1998 - search.proquest.comhttps://search.proquest.com/openview/efc6c811698fb9d7244ceb7031b5b479/1?pq-origsite=gscholar&cbl=18750&diss=y Processing of Exogenous Antigens for IPGP Exchange - J Immunol, 2001 - academia.eduhttps://www.academia.edu/download/70425492/Processing_of_Exogenous_Antigens_for_Pre20210928-6834-8e9kjz.pdf Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance IA York , MA Brehm, S Zendzian - Proceedings of the , 2006 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0603095103 The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation IA York , AXY Mo, K Lemerise, W Zeng, Y Shen - Immunity, 2003 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(03)00058-X.pdf Interferon γ limits the effectiveness of melanoma peptide vaccines HI Cho, YR Lee, E Celis - Blood, The Journal of the American , 2011 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/117/1/135/28755 Origin of Peptides Presented by MHC Class I Molecules: Generation by Proteasomes Precedes Evolution of the Immune System G Niedermann, K Eichmann - Symposium in Immunology VII: Vaccination, 1998 - Springerhttps://link.springer.com/content/pdf/10.1007/978-3-642-80466-3.pdf#page=12 Anti-Peptide Antibody Blocks Peptide E Reticulum - J Immunol, 2001 - researchgate.nethttps://www.researchgate.net/profile/Craig-Hilton/publication/12092680_Anti-Peptide_Antibody_Blocks_Peptide_Binding_to_MHC_Class_I_Molecules_in_the_Endoplasmic_Reticulum/links/5de01809a6fdcc2837f3d244/Anti-Peptide-Antibody-Blocks-Peptide-Binding-to-MHC-Class-I-Molecules-in-the-Endoplasmic-Reticulum.pdf Studying interactions involving the T-cell antigen receptor by surface plasmon resonance DH Margulies , D Plaksin, SN Khilko - Current opinion in , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0952791596800665 In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes D Nelson, C Bundell, B Robinson - The Journal of Immunology, 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/11/6123/33687 Functional endogenous cytotoxic T lymphocytes are generated to multiple antigens co-expressed by progressing tumors; after intra-tumoral IL-2 therapy these effector CS Bundell, C Jackaman , A Suhrbier - Cancer Immunology , 2006 - Springerhttps://link.springer.com/article/10.1007/s00262-005-0086-6 Immune Recognition and Editing of Tumours Expressing Multiple Antigenic Epitopes in Two Murine Models CS Bundell - 2006 - research-repository.uwa.edu.auhttps://research-repository.uwa.edu.au/files/3229331/Bundell_Christine_S_2006.pdf Anti-peptide antibody blocks peptide binding to MHC class I molecules in the endoplasmic reticulum CJ Hilton , AM Dahl, KL Rock - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/166/6/3952/70418 Anti-Peptide Antibody Blocks Peptide CJ Hilton , AM Dahl, KL Rock - scholar.archive.orghttps://scholar.archive.org/work/c72ogauyunfuhgex7k36gpd7w4/access/wayback/http://www.umassmed.edu/uploadedFiles/otm2/Ready_to_sign/00-32%20Ref.pdf CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and C Jackaman , JK Gardner, F Tomay , J Spowart - , 2019 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2018.1564452 Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo C Jackaman , D Majewski, SA Fox , AK Nowak - Cancer Immunology , 2012 - Springerhttps://link.springer.com/article/10.1007/s00262-012-1307-4 Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides AXY Mo, SFL van Lelyveld, A Craiu - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/164/8/4003/32649

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP43742 H-KVVRFDKL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".